Cargando…

A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men

Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Phys...

Descripción completa

Detalles Bibliográficos
Autores principales: Beiraghdar, Fatemeh, Einollahi, Behzad, Ghadyani, Alireza, Panahi, Yunes, Hadjiakhoondi, Abbas, Vazirian, Mahdi, Salarytabar, Ali, Darvishi, Behrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130621/
https://www.ncbi.nlm.nih.gov/pubmed/28532232
http://dx.doi.org/10.1080/13880209.2017.1328445
_version_ 1783353973580759040
author Beiraghdar, Fatemeh
Einollahi, Behzad
Ghadyani, Alireza
Panahi, Yunes
Hadjiakhoondi, Abbas
Vazirian, Mahdi
Salarytabar, Ali
Darvishi, Behrad
author_facet Beiraghdar, Fatemeh
Einollahi, Behzad
Ghadyani, Alireza
Panahi, Yunes
Hadjiakhoondi, Abbas
Vazirian, Mahdi
Salarytabar, Ali
Darvishi, Behrad
author_sort Beiraghdar, Fatemeh
collection PubMed
description Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm(3) were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 ± 2.04%), frequency of urination (20.08 ± 1.02%), intermittency (40.78 ± 2.16%), urgency (60.91 ± 3.14%), weak stream (50.58 ± 2.14%), straining (55.67 ± 2.53%) and nocturia (40.14 ± 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 ± 0.89%) and extant urine volume (28.12 ± 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH.
format Online
Article
Text
id pubmed-6130621
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-61306212018-09-27 A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men Beiraghdar, Fatemeh Einollahi, Behzad Ghadyani, Alireza Panahi, Yunes Hadjiakhoondi, Abbas Vazirian, Mahdi Salarytabar, Ali Darvishi, Behrad Pharm Biol Research Article Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm(3) were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 ± 2.04%), frequency of urination (20.08 ± 1.02%), intermittency (40.78 ± 2.16%), urgency (60.91 ± 3.14%), weak stream (50.58 ± 2.14%), straining (55.67 ± 2.53%) and nocturia (40.14 ± 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 ± 0.89%) and extant urine volume (28.12 ± 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH. Taylor & Francis 2017-05-23 /pmc/articles/PMC6130621/ /pubmed/28532232 http://dx.doi.org/10.1080/13880209.2017.1328445 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Beiraghdar, Fatemeh
Einollahi, Behzad
Ghadyani, Alireza
Panahi, Yunes
Hadjiakhoondi, Abbas
Vazirian, Mahdi
Salarytabar, Ali
Darvishi, Behrad
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_full A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_fullStr A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_full_unstemmed A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_short A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_sort two-week, double-blind, placebo-controlled trial of viola odorata, echium amoenum and physalis alkekengi mixture in symptomatic benign prostate hyperplasia (bph) men
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130621/
https://www.ncbi.nlm.nih.gov/pubmed/28532232
http://dx.doi.org/10.1080/13880209.2017.1328445
work_keys_str_mv AT beiraghdarfatemeh atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT einollahibehzad atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT ghadyanialireza atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT panahiyunes atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT hadjiakhoondiabbas atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT vazirianmahdi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT salarytabarali atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT darvishibehrad atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT beiraghdarfatemeh twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT einollahibehzad twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT ghadyanialireza twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT panahiyunes twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT hadjiakhoondiabbas twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT vazirianmahdi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT salarytabarali twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT darvishibehrad twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen